Clinical trial Recruiting at 1 site Interventional Ages 16 to 70

Buffered lidocaine for myofascial pain: a comparison with lidocaine alone

Official title: Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome Using Surface Electromyography (sEMG)

Run by Cairo University · NCT07572994 · Data updated 2026-11-12

This study tests whether adding sodium bicarbonate to lidocaine can improve pain relief for people with myofascial pain syndrome.

More Trigger Point Pain, Myofascial trials

Quick facts

Study typeInterventional
Ages16 Years to 70 Years
SexAll
Enrollment30 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Cairo Governorate)
StatusRecruiting
StartedNovember 1, 2026
Main results expectedApril 1, 2027
Study endsJune 1, 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07572994 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Candidates are adults 16–70 with diagnosed myofascial pain syndrome and active trigger points who have not had a trigger point injection in the past 3 months and can consent to participation.

Probably not a fit

Patients unlikely to benefit include those with lidocaine or bicarbonate allergies, those with active infections at the injection site, or those with exclusionary conditions such as fibromyalgia or major psychiatric disorders.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel-group, single-blind trial compares lidocaine alone to lidocaine buffered with sodium bicarbonate for trigger point injections in myofascial pain syndrome. Outcome measures include pain scores and functional assessments, with surface electromyography used to characterize muscle activity. Eligible participants are aged 16 to 70 with documented MPS and active trigger points, and follow-up visits monitor safety and response to treatment. The study aims to see if buffering lidocaine provides faster onset, less injection pain, and longer-lasting relief than lidocaine alone. Lead sponsorship is Cairo University, conducted at the Faculty of Dentistry in Cairo, with no listed collaborators.

Why it matters

Potential benefit: If successful, patients may experience faster onset and longer-lasting pain relief from trigger point injections with buffered lidocaine.

How similar studies have gone: Past research suggests buffering lidocaine can reduce injection pain and may speed onset, but evidence in myofascial pain management remains limited, making this study relatively novel in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients aged 16 to 70 years Clinical diagnosis of myofascial pain syndrome (MPS) Presence of active myofascial trigger points Pain duration ≥ 3 months Pain intensity ≥ 4 on the Visual Analog Scale (VAS) Trigger points located in accessible muscles No trigger point injection in the affected area within the past 3 months Ability and willingness to provide informed consent Willingness to comply with study procedures and follow-up visits

Exclusion Criteria:

Known allergy or hypersensitivity to lidocaine, sodium bicarbonate, or other amide-type local anesthetics Current use of anticoagulants or presence of bleeding disorders Local or systemic infection at or near the injection site History of fibromyalgia, cancer-related pain, or central pain syndromes Major psychiatric disorders (e.g., schizophrenia, severe depression) Recent trauma or surgery to the neck, shoulder, or back within the past 6 months Use of analgesics (e.g., NSAIDs, opioids) within 5 days prior to injection Severe systemic diseases (e.g., uncontrolled diabetes, liver failure, kidney failure, severe cardiovascular disease)

\-

Where it's running

  • Faculty of Dentistry Cairo University
    Cairo, Cairo Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.